2008
DOI: 10.1016/j.jri.2007.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Anti-apoptotic seminal vesicle protein IV inhibits cell-mediated immunity

Abstract: The in vitro effect of the seminal vesicle protein IV (SV-IV) on the cytotoxic activity of human natural or acquired cellular immunity has been investigated by standard immunological procedures, a 51 Cr-release cytotoxicity assay, and

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
7
0

Year Published

2008
2008
2013
2013

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(9 citation statements)
references
References 31 publications
2
7
0
Order By: Relevance
“…These results: (a) are in line with the antiapoptotic and immunosuppressive properties of SV-IV [13,17,19,20,21,22,23,24,28]; (b) confirm a modulatory activity of this protein on mammal inflammation reactivity by either inhibiting the arachidonate cascade pathway [19,21] or stimulating the release of proinflammatory cytokines from lymphocytes/monocytes [13] and histamine from FcεRI+ cells; (c) raise the possibility of a protective role of SV-IV on implanting hemiallogenic blastocyst against reactive oxygen species and maternal immunological attacks at the uterine implantation site in concert with other local immunosuppressive cells (mast cells and CD4+CD25+ FoxP3+ regulatory T cells), cytokines (TGF-β 1 , IL-10), and antiapoptotic factors (leukemia inhibitory factor, heme oxygenase 1, peroxidases and histamine).…”
Section: Introductionsupporting
confidence: 67%
See 4 more Smart Citations
“…These results: (a) are in line with the antiapoptotic and immunosuppressive properties of SV-IV [13,17,19,20,21,22,23,24,28]; (b) confirm a modulatory activity of this protein on mammal inflammation reactivity by either inhibiting the arachidonate cascade pathway [19,21] or stimulating the release of proinflammatory cytokines from lymphocytes/monocytes [13] and histamine from FcεRI+ cells; (c) raise the possibility of a protective role of SV-IV on implanting hemiallogenic blastocyst against reactive oxygen species and maternal immunological attacks at the uterine implantation site in concert with other local immunosuppressive cells (mast cells and CD4+CD25+ FoxP3+ regulatory T cells), cytokines (TGF-β 1 , IL-10), and antiapoptotic factors (leukemia inhibitory factor, heme oxygenase 1, peroxidases and histamine).…”
Section: Introductionsupporting
confidence: 67%
“…The possibility that histamine release induced by SV-IV could be related to a generic toxicity or a proapoptotic effect of SV-IV on its target cells is, however, ruled out by several published data showing that SV-IV is nontoxic and strongly antiapoptotic [17,28]. In addition, treatment of FcεRI+ cells with 10–30 µ M SV-IV in short- and long-time incubations does not produce any significant change in cell viability, as measured by the LDH assay.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations